{ event: "article_read", name: `Complications aiguës du diabète: Les SGLT-2`, author: ``, tags: `Diabète`, publication_date: ``, interaction_type: "content" } 
Explorer Explorer
Complications aiguës du diabète: Les SGLT-2
20210617_Sanofi_podcast18_DrDerdelincks_FR_v1 4 les inhibiteurs SGLT-2
Articles liés
Personalized approach in T2D is key for success
The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.
Webinaire enregistré du 27 mars 2024 avec le Dr Gertjan Vereecke Diabète
Vous ne voyez pas la forêt derrière les arbres ?
